Orion Corporation A (ORNAV.HE) Financials
ORNAV.HE Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.4 billion | 548.5 million |
2023-09-30 | 1.4 billion | 531.7 million |
2023-06-30 | 1.3 billion | 539.9 million |
2023-03-31 | 1.3 billion | 564.3 million |
ORNAV.HE Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 26.7 million | ? |
2023-09-30 | 9.7 million | ? |
2023-06-30 | 15.7 million | ? |
2023-03-31 | -49.8 million | ? |
ORNAV.HE Net Income
Date | Net Income |
---|---|
2023-12-31 | 75.1 million |
2023-09-30 | 61.4 million |
2023-06-30 | 45.8 million |
2023-03-31 | 55.1 million |
ORNAV.HE Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 8.1 million |
2023-09-30 | 77.9 million | 176.8 million | - |
2023-06-30 | 74.6 million | 183.2 million | - |
2023-03-31 | 99.8 million | 189.7 million | - |
ORNAV.HE Shares Outstanding
ORNAV.HE Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 22.1 million | 36.6 million | 83.1 million | - |
2023-09-30 | 94.7 million | 27.2 million | 64.4 million | - |
2023-06-30 | 17.5 million | 31.3 million | 21.6 million | 58.9 million |
2023-03-31 | 53.8 million | 31.7 million | 17.8 million | 53.8 million |
ORNAV.HE Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 321.1 million | 144.3 million |
2023-09-30 | 301.1 million | 129.8 million |
2023-06-30 | 289.5 million | 136.0 million |
2023-03-31 | 278.0 million | 121.8 million |
ORNAV.HE
Price: €37.75
Dividend Yield: 0.04%
Forward Dividend Yield: 2.15%
Payout Ratio: 52.60%
Dividend Per Share: 0.81 EUR
Earnings Per Share: 1.54 EUR
P/E Ratio: 33.99
Exchange: HEL
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 5.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 18.89%
DGR5: 12.02%
DGR10: 7.15%